Input keywords, title, abstract, author, affiliation etc..
Journal Article An open access journal
Journal Article

The Efficacy of Mindfulness-Based Cognitive Therapy (MBCT) for Recurrent Depression: A Meta-Analysis of Randomized Controlled Trials

by Tessa Calderon 1,*
1
University of Pecs
*
Author to whom correspondence should be addressed.
JPHE  2023 6(2):227; https://doi.org/10.xxxx/xxxxxx
Received: 18 August 2023 / Accepted: 15 September 2023 / Published Online: 1 December 2023

Abstract

Mindfulness-Based Cognitive Therapy (MBCT) has emerged as a promising intervention for preventing relapse and recurrence of depression, combining cognitive therapy techniques with mindfulness practices to target cognitive reactivity and promote self-regulation skills. This meta-analysis of randomized controlled trials (RCTs) evaluates the efficacy of MBCT in reducing depressive relapse/recurrence and improving overall well-being in individuals with a history of recurrent depression. Through an extensive literature review, the meta-analysis synthesizes effect sizes from RCTs assessing the effectiveness of MBCT compared to control conditions (e.g., treatment as usual, maintenance antidepressant medication, placebo) in preventing depressive relapse/recurrence and reducing residual depressive symptoms. Additionally, it examines potential moderators of treatment outcomes, such as treatment duration, frequency of sessions, therapist involvement, and participant characteristics (e.g., history of depression, comorbidities), to better understand the factors influencing the effectiveness of MBCT for recurrent depression.


Copyright: © 2023 by Calderon. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (Creative Commons Attribution 4.0 International License). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Share and Cite

ACS Style
Calderon, T. The Efficacy of Mindfulness-Based Cognitive Therapy (MBCT) for Recurrent Depression: A Meta-Analysis of Randomized Controlled Trials. Journal of Public Health & Environment, 2023, 6, 227. doi:10.xxxx/xxxxxx
AMA Style
Calderon T. The Efficacy of Mindfulness-Based Cognitive Therapy (MBCT) for Recurrent Depression: A Meta-Analysis of Randomized Controlled Trials. Journal of Public Health & Environment; 2023, 6(2):227. doi:10.xxxx/xxxxxx
Chicago/Turabian Style
Calderon, Tessa 2023. "The Efficacy of Mindfulness-Based Cognitive Therapy (MBCT) for Recurrent Depression: A Meta-Analysis of Randomized Controlled Trials" Journal of Public Health & Environment 6, no.2:227. doi:10.xxxx/xxxxxx

Article Metrics

Article Access Statistics

References

  1. Segal, Z. V., et al. (2002). Mindfulness-based cognitive therapy for depression: A new approach to preventing relapse. Guilford Press.
  2. Kuyken, W., et al. (2016). Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): A randomised controlled trial. The Lancet, 386(9988), 63-73.
  3. Teasdale, J. D., et al. (2000). Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Journal of Consulting and Clinical Psychology, 68(4), 615-623.
  4. Ma, S. H., & Teasdale, J. D. (2004). Mindfulness-based cognitive therapy for depression: Replication and exploration of differential relapse prevention effects. Journal of Consulting and Clinical Psychology, 72(1), 31-40.
  5. Williams, J. M. G., et al. (2008). Mindfulness-based cognitive therapy for preventing relapse in recurrent depression: A randomized dismantling trial. Journal of Consulting and Clinical Psychology, 76(6), 966-978.
  6. Eisendrath, S. J., et al. (2016). A randomized controlled trial of mindfulness-based cognitive therapy for treatment-resistant depression. Psychotherapy and Psychosomatics, 85(2), 99-110.